Ulyana Munoz Acuna1, Nathan Ezzone1, L Harinantenaina Rakotondraibe1, Esperanza J Carcache DE Blanco2. 1. Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH, U.S.A. 2. Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH, U.S.A. carcachedeblanco.1@osu.edu.
Abstract
BACKGROUND/AIM: Effect of capsicodendrin on the NF-κB pathway was studied in MCF-7 cancer cells. MATERIALS AND METHODS: The transcription factor assay was used to screen for NF-κB activity. The effect on IKKβ, ICAM-1, and caspase-7 were studied using western blot. Caspase-1 was studied using Promega Caspase-Glo® assay. Reactive oxygen species (ROS) were detected using the fluorescent probe DCFH-DA. The potentiometric dye JC-1 was used to assess mitochondrial membrane potential (ΔΨm) and the cell cycle was examined using a fluorescence-activated cell sorter. RESULTS: NF-κB p65 inhibitory effect was IC50=8.6 μM and cytotoxic activity was IC50=7.5 μM. The upstream IKK and the downstream ICAM-1 were down-regulated. Sub G1-phase population increased to 81% after 12 h of treatment with capsicodendrin (10 μM) and there was no loss of ΔΨM. CONCLUSION: Increased levels of intracellular ROS promoted activity of caspase-1 and induced cell death in MCF-7 cells. Capsicodendrin may be a future anticancer agent that prevents the progression of metastatic breast cancer.
BACKGROUND/AIM: Effect of capsicodendrin on the NF-κB pathway was studied in MCF-7 cancer cells. MATERIALS AND METHODS: The transcription factor assay was used to screen for NF-κB activity. The effect on IKKβ, ICAM-1, and caspase-7 were studied using western blot. Caspase-1 was studied using Promega Caspase-Glo® assay. Reactive oxygen species (ROS) were detected using the fluorescent probe DCFH-DA. The potentiometric dye JC-1 was used to assess mitochondrial membrane potential (ΔΨm) and the cell cycle was examined using a fluorescence-activated cell sorter. RESULTS: NF-κB p65 inhibitory effect was IC50=8.6 μM and cytotoxic activity was IC50=7.5 μM. The upstream IKK and the downstream ICAM-1 were down-regulated. Sub G1-phase population increased to 81% after 12 h of treatment with capsicodendrin (10 μM) and there was no loss of ΔΨM. CONCLUSION: Increased levels of intracellular ROS promoted activity of caspase-1 and induced cell death in MCF-7 cells. Capsicodendrin may be a future anticancer agent that prevents the progression of metastatic breast cancer.
Authors: F Cardoso; A Costa; L Norton; D Cameron; T Cufer; L Fallowfield; P Francis; J Gligorov; S Kyriakides; N Lin; O Pagani; E Senkus; C Thomssen; M Aapro; J Bergh; A Di Leo; N El Saghir; P A Ganz; K Gelmon; A Goldhirsch; N Harbeck; N Houssami; C Hudis; B Kaufman; M Leadbeater; M Mayer; A Rodger; H Rugo; V Sacchini; G Sledge; L van't Veer; G Viale; I Krop; E Winer Journal: Breast Date: 2012-03-16 Impact factor: 4.380
Authors: Christopher C Pan; Nirav Shah; Sanjay Kumar; Sarah E Wheeler; Jason Cinti; Dale G Hoyt; Christine E Beattie; Min An; Karthikeyan Mythreye; L Harinantenaina Rakotondraibe; Nam Y Lee Journal: Oncotarget Date: 2017-02-21
Authors: K Viola; S Kopf; N Huttary; C Vonach; N Kretschy; M Teichmann; B Giessrigl; I Raab; S Stary; S Krieger; T Keller; S Bauer; B Hantusch; T Szekeres; R de Martin; W Jäger; W Mikulits; H Dolznig; G Krupitza; M Grusch Journal: Br J Cancer Date: 2012-10-23 Impact factor: 7.640
Authors: Stine L Figenschau; Erik Knutsen; Ilona Urbarova; Christopher Fenton; Bryan Elston; Maria Perander; Elin S Mortensen; Kristin A Fenton Journal: Sci Rep Date: 2018-08-06 Impact factor: 4.379